Page 69 - Annual Report
P. 69

HONG KONG ACADEMY OF MEDICINE
                 香港醫學專科學院
                               院
                             學
                         專
                     醫
                       學
                 香
                           科
                   港
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
                 FOR THE YEAR ENDED 31 DECEMBER 2021




                 3.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

                      c)   Basis of consolidation (Continued)

                          x     rights arising from other contractual arrangements; and

                          x     any additional facts and circumstances that indicate that the Group has, or does
                                not  have,  the  current  ability  to  direct  the  relevant  activities  at  the  time  that
                                decisions  need  to  be  made,  including  voting  patterns  at  previous  members’
                                meetings.

                          Consolidation  of  a  structured  entity  begins  when  the  Group  obtains  control  over  the
                          structured  entity  and  ceases  when  the  Group  loses  control  of  the  structured  entity.
                          Specifically, income and expenses of a structured entity acquired or disposed of during
                          the year are included in the consolidated statement of profit or loss from the date the
                          Group  gains  control  until  the  date  when  the  Group  ceases  to  control  the  structured
                          entity.

                          When  necessary,  adjustments  are  made  to  the  consolidated  financial  statements  of
                          structured  entity  to  bring  its  accounting  policies  in  line  with  the  Group’s  accounting
                          policies.

                          All intragroup assets and liabilities, equity, income, expenses and cash flows relating to
                          transactions between members of the Group are eliminated in full on consolidation.

                      d)   Property, plant and equipment

                          Property,  plant  and  equipment  are  stated  at  cost  less  accumulated  depreciation  and
                          impairment losses (see note 3(g)).

                          x     right-of-use  assets  arising  from  leases  over  freehold  or  leasehold  properties
                                where the Group is not the registered owner of the property interest; and

                          x     items of plant and equipment, including right-of-use assets arising from leases of
                                underlying plant and equipment (see note 3(e)).

                          Historical cost includes expenditure that is directly attributable to the acquisition of the
                          items.

                          Subsequent  costs  are  included  in  the  asset’s  carrying  amount  or  recognised  as  a
                          separate asset, as appropriate, only when it is probable that future economic benefits
                          associated with the item will flow to the Group and the cost of the item can be measured
                          reliably. The carrying amount of the replaced part is derecognised. All other repairs and
                          maintenance are recognised in profit or loss during the financial period in which they are
                          incurred.

                          An asset’s carrying amount is written down immediately to its recoverable amount if the
                          asset’s carrying amount is greater than its estimated recoverable amount.

                          Depreciation is calculated to write off the cost of items of property, plant and equipment
                          using the straight line method over their estimated useful lives as follows:

                                                            11
                                                           11




                                                                                   香港醫學專科學院 2022 年度報告              67
   64   65   66   67   68   69   70   71   72   73   74